Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

37
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

14
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

9
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
9
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

15
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
15
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experience of Australian rheumatologists managing polymyalgia rheumatica: results from a national survey.

Internal medicine journal·2026
Same author

Current clinical practice trends in giant cell arteritis diagnosis and management: a national survey of Australian rheumatologists and rheumatology trainees.

Internal medicine journal·2026
Same author

Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic <sup>18</sup>F-FDG PET/CT findings.

European journal of nuclear medicine and molecular imaging·2025
Same author

Changes to physical function and body composition during the first 2 years of polymyalgia rheumatica.

Rheumatology (Oxford, England)·2025
Same author

More Than Pain and Stiffness: Persistent Fatigue and Sleep Disturbance in Polymyalgia Rheumatica.

The Journal of rheumatology·2025
Same author

Case report: Lipoprotein (a) related accelerated atherosclerosis in a young patient: An important differential when considering Takayasu arteritis.

International journal of rheumatic diseases·2024

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

2.2K

Exploring the patient experience in polymyalgia rheumatica.

Georgia K Harris1,2, Jessica L Leung3,4, Russell R C Buchanan3,4

  • 1Department of Rheumatology, Austin Health, Heidelberg, VIC, Australia. georgia.k.harris@gmail.com.

Clinical Rheumatology
|October 20, 2023
PubMed
Summary
This summary is machine-generated.

Polymyalgia rheumatica (PMR) patients experience diagnostic delays and complex feelings about steroid treatments. This common elderly inflammatory disease may be chronic, not self-limiting, requiring new outcome measures.

Keywords:
ExperiencePatient satisfactionPolymyalgia rheumaticaQualitative research

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

425
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

198

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

2.2K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

425
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

198

Area of Science:

  • Rheumatology
  • Geriatric Medicine
  • Patient-Reported Outcomes

Background:

  • Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in the elderly.
  • Limited research has focused on the patient experience of PMR.
  • Understanding patient perspectives is crucial for improving care and treatment strategies.

Discussion:

  • Patient experiences reveal significant delays in diagnosis, impacting timely management.
  • Attitudes towards glucocorticoid therapy are complex, balancing efficacy with side effects.
  • There is a clear patient desire for alternative treatment options beyond corticosteroids.

Key Insights:

  • PMR diagnosis is often delayed, leading to prolonged symptoms and patient distress.
  • Glucocorticoid treatment presents a complex challenge for patients, highlighting the need for nuanced management.
  • Patients actively seek non-glucocorticoid treatment strategies for polymyalgia rheumatica.

Outlook:

  • Future clinical trials for PMR should incorporate physical function as a primary outcome measure.
  • The chronicity of PMR symptoms challenges the traditional view of it as a self-limiting condition.
  • Further research into patient-centered care models and alternative therapies is warranted.